NAS:BIOS (USA) Also trade in: Germany

BioScrip Inc

$ 2.34 0.12 (5.41%)
On watch
Volume: 2,015,731 Avg Vol (1m): 1,006,412
Market Cap $: 301.29 Mil Enterprise Value $: 806.84 Mil
P/E (TTM): 0.00 P/B: 0.00
Earnings Power Value -1.86
Net Current Asset Value -4.43
Tangible Book -4.05
Projected FCF -4.99
Median P/S Value 2.29
Graham Number 0
Peter Lynch Value 0
DCF (FCF Based) 0
DCF (Earnings Based) 0
1Y (-%)

Financial Strength : 3/10

GuruFocus Financial Strength Rank measures how strong a company's financial situation is . It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
Current vs industry vs history
Cash-to-Debt 0.01
Cash-To-Debt ranked lower than
77.01% of 274 companies
in the Medical Care industry.
Industry Max: 10000, Med: 0.28, Min: 0.01
BIOS: 0.01
Ranked among companies with meaningful Cash-To-Debt only.
Cash-To-Debt range over the past 10 years
Min: 0, Med: 0.36, Max: 10000
Current: 0.01
0
10000
Equity-to-Asset -0.26
Equity-to-Asset ranked lower than
95.91% of 269 companies
in the Medical Care industry.
Industry Max: 0.97, Med: 0.48, Min: -15.93
BIOS: -0.26
Ranked among companies with meaningful Equity-to-Asset only.
Equity-to-Asset range over the past 10 years
Min: -0.26, Med: 0.39, Max: 0.75
Current: -0.26
-0.26
0.75
Debt-to-Equity -3.27
Debt-to-Equity ranked lower than
100.00% of 202 companies
in the Medical Care industry.
Industry Max: 25.64, Med: 0.64, Min: 0.01
BIOS: -3.27
Ranked among companies with meaningful Debt-to-Equity only.
Debt-to-Equity range over the past 10 years
Min: -22.1, Med: 0.1, Max: 2.05
Current: -3.27
-22.1
2.05
Debt-to-EBITDA 12.21
Debt-to-EBITDA ranked lower than
98.51% of 201 companies
in the Medical Care industry.
Industry Max: 66.84, Med: 2.81, Min: 0.01
BIOS: 12.21
Ranked among companies with meaningful Debt-to-EBITDA only.
Debt-to-EBITDA range over the past 10 years
Min: -17.97, Med: 8.23, Max: 12.32
Current: 12.21
-17.97
12.32
Interest Coverage 0.33
Interest Coverage ranked lower than
98.68% of 227 companies
in the Medical Care industry.
Industry Max: 48765, Med: 6.85, Min: 0.01
BIOS: 0.33
Ranked among companies with meaningful Interest Coverage only.
Interest Coverage range over the past 10 years
Min: 0.3, Med: 0.84, Max: 8.98
Current: 0.33
0.3
8.98
Piotroski F-Score 3
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -0.20
DISTRESS
GREY
SAFE
Beneish M-Score -2.59
Not Manipulator
Manipulator

Profitability & Growth : 3/10

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.
Current vs industry vs history
Operating Margin % 2.74
Operating Margin ranked lower than
76.47% of 272 companies
in the Medical Care industry.
Industry Max: 66.83, Med: 6.83, Min: -3742
BIOS: 2.74
Ranked among companies with meaningful Operating Margin only.
Operating Margin range over the past 10 years
Min: 1.29, Med: 3.17, Max: 8.1
Current: 2.74
1.29
8.1
Net Margin % -6.81
Net Margin ranked lower than
84.93% of 272 companies
in the Medical Care industry.
Industry Max: 202.55, Med: 3.88, Min: -4897.7
BIOS: -6.81
Ranked among companies with meaningful Net Margin only.
Net Margin range over the past 10 years
Min: -30.56, Med: -7.58, Max: 10.9
Current: -6.81
-30.56
10.9
ROA % -8.40
ROA ranked lower than
89.01% of 273 companies
in the Medical Care industry.
Industry Max: 52.42, Med: 3.48, Min: -3383.78
BIOS: -8.4
Ranked among companies with meaningful ROA only.
ROA range over the past 10 years
Min: -44.29, Med: -8.77, Max: 20.26
Current: -8.4
-44.29
20.26
ROC (Joel Greenblatt) % 26.46
ROC (Joel Greenblatt) ranked lower than
86.76% of 272 companies
in the Medical Care industry.
Industry Max: 8470.37, Med: 14.91, Min: -33236.56
BIOS: 26.46
Ranked among companies with meaningful ROC (Joel Greenblatt) only.
ROC (Joel Greenblatt) range over the past 10 years
Min: -35.46, Med: 24.32, Max: 114.16
Current: 26.46
-35.46
114.16
3-Year Total Revenue Growth Rate -10.30
3-Year Revenue Growth Rate ranked lower than
79.62% of 211 companies
in the Medical Care industry.
Industry Max: 314.7, Med: 6.5, Min: -100
BIOS: -27.1
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
3-Year Revenue Growth Rate range over the past 10 years
Min: -35, Med: 3.3, Max: 15.9
Current: -27.1
-35
15.9
3-Year Total EBITDA Growth Rate -7.70
3-Year EBITDA Growth Rate ranked lower than
100.00% of 184 companies
in the Medical Care industry.
Industry Max: 236.4, Med: 5.9, Min: -108
BIOS: -25
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
N/A
3-Year EPS w/o NRI Growth Rate 52.50
3-Year EPS w/o NRI Growth Rate ranked higher than
73.46% of 162 companies
in the Medical Care industry.
Industry Max: 136.6, Med: 8.4, Min: -146.6
BIOS: 52.5
Ranked among companies with meaningful 3-Year EPS w/o NRI Growth Rate only.
3-Year EPS w/o NRI Growth Rate range over the past 10 years
Min: 0, Med: -37, Max: 82.7
Current: 52.5
0
82.7

» BIOS's 30-Y Financials

Financials (Next Earnings Date: 2019-08-07)

Guru Trades Click for details

» Details

Insider Trades

SEC Filings

Gurus Latest Trades with NAS:BIOS

» Interactive Chart

Peter Lynch Chart

Business Description

Industry Health Care Providers » Medical Care    NAICS : 621610    SIC : 8082
Compare BKK:NTV-F BKK:PR9 NSE:HCG XTER:M12 OHEL:PIHLIS ADX:GMPC HKSE:03869 HKSE:00383 HKSE:03689 NSE:MAXINDIA XTER:MED BKK:SKR-F BKK:CMR-F TSX:DR SGX:QC7 OTCPK:NVOS HKSE:01526 NAS:JYNT XKLS:0101 NAS:CATS
Traded in other countries MM6.Germany
Address 1600 Broadway, Suite 700, Denver, CO, USA, 80202
BioScrip Inc is one of the largest providers of home infusion services and home care management solutions in the United States. The firm's home infusion services primarily involve the intravenous administration of medications treating a wide range of acute and chronic conditions, such as infections, nutritional deficiencies, various immunologic and neurologic disorders, cancer, pain and palliative care. It provides a wide array of home infusion products and services to meet the diverse needs of physicians, patients, and payors. Its other services include anti-infective therapy, cardiac care, nutrition support, immunoglobulin therapy, hemophilia care, and respiratory/HME.

Ratios

Current vs industry vs history
PS Ratio 0.42
PS Ratio ranked higher than
90.08% of 262 companies
in the Medical Care industry.
Industry Max: 79.41, Med: 1.7, Min: 0.03
BIOS: 0.42
Ranked among companies with meaningful PS Ratio only.
PS Ratio range over the past 10 years
Min: 0.04, Med: 0.41, Max: 1.89
Current: 0.42
0.04
1.89
EV-to-EBIT 41.00
EV-to-EBIT ranked lower than
100.00% of 214 companies
in the Medical Care industry.
Industry Max: 3101.61, Med: 21.68, Min: 1.06
BIOS: 41
Ranked among companies with meaningful EV-to-EBIT only.
EV-to-EBIT range over the past 10 years
Min: -249.1, Med: 18, Max: 131.6
Current: 41
-249.1
131.6
EV-to-EBITDA 19.27
EV-to-EBITDA ranked lower than
91.23% of 228 companies
in the Medical Care industry.
Industry Max: 1827.89, Med: 15.23, Min: 0.9
BIOS: 19.27
Ranked among companies with meaningful EV-to-EBITDA only.
EV-to-EBITDA range over the past 10 years
Min: -62.6, Med: 12.4, Max: 38125.6
Current: 19.27
-62.6
38125.6
EV-to-Revenue 1.12
EV-to-Revenue ranked higher than
82.66% of 271 companies
in the Medical Care industry.
Industry Max: 158.19, Med: 2.17, Min: 0.06
BIOS: 1.12
Ranked among companies with meaningful EV-to-Revenue only.
EV-to-Revenue range over the past 10 years
Min: 0.1, Med: 0.9, Max: 3
Current: 1.12
0.1
3
Current Ratio 1.48
Current Ratio ranked higher than
68.85% of 260 companies
in the Medical Care industry.
Industry Max: 13.59, Med: 1.34, Min: 0.04
BIOS: 1.48
Ranked among companies with meaningful Current Ratio only.
Current Ratio range over the past 10 years
Min: 0.86, Med: 1.37, Max: 2.76
Current: 1.48
0.86
2.76
Quick Ratio 1.24
Quick Ratio ranked higher than
63.85% of 260 companies
in the Medical Care industry.
Industry Max: 13.59, Med: 1.24, Min: 0.04
BIOS: 1.24
Ranked among companies with meaningful Quick Ratio only.
Quick Ratio range over the past 10 years
Min: 0.79, Med: 1.18, Max: 2.5
Current: 1.24
0.79
2.5
Days Inventory 22.21
Days Inventory ranked lower than
53.40% of 206 companies
in the Medical Care industry.
Industry Max: 464.03, Med: 17.07, Min: 0.09
BIOS: 22.21
Ranked among companies with meaningful Days Inventory only.
Days Inventory range over the past 10 years
Min: 15.25, Med: 24.31, Max: 80.5
Current: 22.21
15.25
80.5
Days Sales Outstanding 47.74
Days Sales Outstanding ranked higher than
53.74% of 227 companies
in the Medical Care industry.
Industry Max: 524.5, Med: 39.87, Min: 0.25
BIOS: 47.74
Ranked among companies with meaningful Days Sales Outstanding only.
Days Sales Outstanding range over the past 10 years
Min: 36.18, Med: 59.14, Max: 178.08
Current: 47.74
36.18
178.08
Days Payable 59.69
Days Payable ranked lower than
64.20% of 176 companies
in the Medical Care industry.
Industry Max: 1871.61, Med: 40.58, Min: 1
BIOS: 59.69
Ranked among companies with meaningful Days Payable only.
Days Payable range over the past 10 years
Min: 23.22, Med: 45.66, Max: 109.18
Current: 59.69
23.22
109.18

Dividend & Buy Back

Current vs industry vs history
3-Year Share Buyback Rate -23.00
3-Year Share Buyback Rate ranked lower than
85.53% of 159 companies
in the Medical Care industry.
Industry Max: 100, Med: -2.5, Min: -549.3
BIOS: -23
Ranked among companies with meaningful 3-Year Share Buyback Rate only.
3-Year Share Buyback Rate range over the past 10 years
Min: -23, Med: -12.4, Max: -0.5
Current: -23
-23
-0.5

Valuation & Return

Current vs industry vs history
Price-to-Median-PS-Value 1.02
Price-to-Median-PS-Value ranked lower than
72.12% of 208 companies
in the Medical Care industry.
Industry Max: 12, Med: 1.03, Min: 0.01
BIOS: 1.02
Ranked among companies with meaningful Price-to-Median-PS-Value only.
Price-to-Median-PS-Value range over the past 10 years
Min: 0.13, Med: 0.59, Max: 3.72
Current: 1.02
0.13
3.72
Earnings Yield (Joel Greenblatt) % 2.44
Earnings Yield (Greenblatt) ranked lower than
80.22% of 273 companies
in the Medical Care industry.
Industry Max: 94.34, Med: 3.61, Min: -217.39
BIOS: 2.44
Ranked among companies with meaningful Earnings Yield (Greenblatt) only.
Earnings Yield (Greenblatt) range over the past 10 years
Min: -84.9, Med: 4.15, Max: 15.4
Current: 2.44
-84.9
15.4
Forward Rate of Return (Yacktman) % -16.86
Forward Rate of Return ranked lower than
88.72% of 133 companies
in the Medical Care industry.
Industry Max: 868.48, Med: 9.1, Min: -81.77
BIOS: -16.86
Ranked among companies with meaningful Forward Rate of Return only.
Forward Rate of Return range over the past 10 years
Min: -16.86, Med: -2.2, Max: 0.3
Current: -16.86
-16.86
0.3

More Statistics

Revenue (TTM) (Mil) $ 719.28
EPS (TTM) $ -0.55
Beta 0
Volatility % 70.3
52-Week Range $ 1.56 - 4.14
Shares Outstanding (Mil) 128.76

Analyst Estimate

Piotroski F-Score Details

Piotroski F-Score 3
Positive ROA N
Positive CFROA N
Higher ROA yoy Y
CFROA > ROA Y
Lower Leverage yoy N
Higher Current Ratio yoy N
Less Shares Outstanding yoy N
Higher Gross Margin yoy Y
Higher Asset Turnover yoy N